Sleep and Biological Rhythms
Leader: Nicolas Cermakian, PhD
The Douglas Group for Sleep and Biological Rhythms is formed of internationally leading experts in the fields of sleep and chronobiology, working both in human and basic research to conduct translational studies on the regulation of sleep and other biological rhythms. In particular, group members study the implications of biological rhythm/sleep disruption in various diseases including mental disorders. The work includes studies on patients with primary circadian rhythm disorders or psychiatric disorders characterized by a high prevalence of disrupted sleep or eating patterns. Team members also aim to understand the clinical implications of living on atypical schedules such as occurs in shift work, as well as elucidating the interplay between youth sleep, health and cognition, and to develop innovative strategies using sleep improvement to enhance youth physical and mental health and daytime functioning. Finally, approaches also involve epidemiology and clinical trials to correct sleep and rhythm disruptions.
|Diane B. Boivin||Study and treatment of human circadian rhythms|
|Nicolas Cermakian||Molecular chronobiology|
|Reut Gruber||Attention, behaviour, and sleep|
|Kai-Florian Storch||Biological rhythms and psychopathology|
|Serge Beaulieu||Bipolar disorders|
|Alain Brunet||Impact of traumatic stress on mental health|
|Bruno Debruille||Cognitive and social neuroscience|
|Serge Gauthier||Alzheimer's disease research|
|Mimi Israel||Eating disorders|
|Ridha Joober||Genetics and pharmacogenetics of psychiatric disorders|
|Lalit Srivastava||Etiopathology of schizophrenia and autism|
|Howard Steiger||Eating disorders|
|Dominique Walker||Early stress, maternal regulation and neuroendocrine development|
|Sylvain Williams||Hippocampal rhythm|
Most psychiatric and neurodegenerative diseases are associated with disturbed sleep and circadian rhythms, including mood disorders, ADHD, eating disorders, autism, schizophrenia, Alzheimer's disease, multiple sclerosis and Parkinson's disease. Similarly, work on atypical schedules increases the risk of various medical and psychiatric conditions. Therefore, sleep and circadian disruption are increasingly considered as significant risk factors for the development or aggravation of mental disorders. In turn, current research starts to address how improving sleep and rhythms could prevent onset of disease, help treat these conditions, or promote cognitive and mental health. Thus, disruption of sleep and biological rhythms are core aspects of most mental disorders, they impact cognitive, emotional and behavioural functioning, and they are involved in their pathophysiology.
Based on this, the general objective of the Douglas Group for Sleep and Biological Rhythms is to consider sleep and biological rhythms in the prevention and treatment of mental disorders, and ultimately to enhance physical and mental wellbeing, cognition, and daytime functioning of different target populations.
More specifically, the aims of the group are:
1) To foster collaborations aiming at elucidating mechanistic links between mental health and illness and sleep/biological rhythms, at the molecular, cellular, physiological, behavioural and clinical levels throughout development and adulthood.
2) To design innovative approaches to promote sleep health and to study and treat sleep and rhythm disruption in vulnerable populations.
3) To create a strong translational training environment for students interested in sleep and biological rhythms.